Which laboratory test is commonly used to monitor LMWH therapy?

Which laboratory test is commonly used to monitor LMWH therapy?

• A. INR
• B. aPTT
• C. D-dimer
• D. anti-Xa

Answer: (D)

Monitoring LMWH therapy relies on measuring anti-Xa activity because LMWH exerts its effect mainly by enhancing antithrombin’s inhibition of factor Xa, and this relationship is more predictable than what you’d see with standard clotting tests. The INR is used with warfarin and doesn’t reflect LMWH activity. The aPTT is designed to assess intrinsic pathway clotting and is variably affected by LMWH, making it unreliable for dosing. D-dimer indicates clot breakdown, not anticoagulant effect. The anti-Xa assay directly quantifies how much factor Xa activity is being inhibited by the LMWH-antithrombin complex, providing a meaningful measure of anticoagulant effect. It’s especially useful in situations where precise dosing is important (renal impairment, extreme body weight, pregnancy, pediatrics) and is typically checked at about 4 hours after a dose to gauge peak activity.

Monitoring LMWH therapy relies on measuring anti-Xa activity because LMWH exerts its effect mainly by enhancing antithrombin’s inhibition of factor Xa, and this relationship is more predictable than what you’d see with standard clotting tests. The INR is used with warfarin and doesn’t reflect LMWH activity. The aPTT is designed to assess intrinsic pathway clotting and is variably affected by LMWH, making it unreliable for dosing. D-dimer indicates clot breakdown, not anticoagulant effect. The anti-Xa assay directly quantifies how much factor Xa activity is being inhibited by the LMWH-antithrombin complex, providing a meaningful measure of anticoagulant effect. It’s especially useful in situations where precise dosing is important (renal impairment, extreme body weight, pregnancy, pediatrics) and is typically checked at about 4 hours after a dose to gauge peak activity.